Biology Reference
In-Depth Information
Bingle, L., Brown, N.J., Lewis, C.E., 2002. The role of tumour-associated macrophages in
tumour progression: implications for new anticancer therapies. J. Pathol. 196, 254-265.
Biswas, S.K., Mantovani, A., 2010. Macrophage plasticity and interaction with lymphocyte
subsets: cancer as a paradigm. Nat. Immunol. 11, 889-896.
Blankenstein, T., Qin, Z.H., Uberla, K., Muller, W., Rosen, H., Volk, H.D., Diamantstein,
T., 1991. Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene
transfer. J. Exp. Med. 173, 1047-1052.
Bottazzi, B., Polentarutti, N., Acero, R., Balsari, A., Boraschi, D., Ghezzi, P., Salmona, M.,
Mantovani, A., 1983. Regulation of the macrophage content of neoplasms by chemoat-
tractants. Science 220, 210-212.
Bottazzi, B., Walter, S., Govoni, D., Colotta, F., Mantovani, A., 1992. Monocyte chemotactic
cytokine gene transfer modulates macrophage infiltration, growth, and susceptibility to
IL-2 therapy of a murine melanoma. J. Immunol. 148, 1280-1285.
Bouhlel, M.A., Derudas, B., Rigamonti, E., Dievart, R., Brozek, J., Haulon, S., Zawadzki,
C., Jude, B., Torpier, G., Marx, N., Staels, B., Chinetti-Gbaguidi, G., 2007. PPARgamma
activation primes human monocytes into alternative M2 macrophages with anti-inflam-
matory properties. Cell. Metab. 6, 137-143.
Brecht, K., Weigert, A., Hu, J., Popp, R., Fisslthaler, B., Korff, T., Fleming, I., Geisslinger, G.,
Brune, B., 2011. Macrophages programmed by apoptotic cells promote angiogenesis via
prostaglandin E2. FASEB J. 25, 2408-2417.
Brooks, P.C., Montgomery, A.M., Rosenfeld, M., Reisfeld, R.A., Hu, T., Klier, G., Cheresh,
D.A., 1994. Integrin alpha v beta 3 antagonists promote tumor regression by inducing
apoptosis of angiogenic blood vessels. Cell 79, 1157-1164.
Burke, B., Tang, N., Corke, K.P., Tazzyman, D., Ameri, K., Wells, M., Lewis, C.E., 2002.
Expression of HIF-1alpha by human macrophages: implications for the use of macro-
phages in hypoxia-regulated cancer gene therapy. J. Pathol. 196, 204-212.
Carmeliet, P., Moons, L., Luttun, A.,Vincenti,V., Compernolle,V., De, M.M., Wu,Y., Bono, F.,
Devy, L., Beck, H., Scholz, D., Acker, T., DiPalma, T., Dewerchin, M., Noel, A., Stalmans,
I., Barra, A., Blacher, S.,Vandendriessche, T., Ponten, A., Eriksson, U., Plate, K.H., Foidart,
J.M., Schaper, W., Charnock-Jones, D.S., Hicklin, D.J., Herbert, J.M., Collen, D., Persico,
M.G., 2001. Synergism between vascular endothelial growth factor and placental growth
factor contributes to angiogenesis and plasma extravasation in pathological conditions.
Nat. Med. 7, 575-583.
Cejudo-Martin, P., Morales-Ruiz, M., Ros, J., Navasa, M., Fernandez-Varo, G., Fuster, J.,
Rivera, F., Arroyo, V., Rodes, J., Jimenez, W., 2002. Hypoxia is an inducer of vasodilator
agents in peritoneal macrophages of cirrhotic patients. Hepatology 36, 1172-1179.
Chabot, S., Jabrane-Ferrat, N., Bigot, K., Tabiasco, J., Provost, A., Golzio, M., Noman, M.Z.,
Giustiniani, J., Bellard, E., Brayer, S., guerre-Girr, M., Meggetto, F., Giuriato, S., Male-
caze, F., Galiacy, S., Jais, J.P., Chose, O., Kadouche, J., Chouaib, S., Teissie, J., Abitbol, M.,
Bensussan, A., Le, B.P., 2011. A novel antiangiogenic and vascular normalization therapy
targeted against human CD160 receptor. J. Exp. Med. 208, 973-986.
Chan, D.A., Kawahara, T.L., Sutphin, P.D., Chang, H.Y., Chi, J.T., Giaccia, A.J., 2009. Tumor
vasculature is regulated by PHD2-mediated angiogenesis and bone marrow-derived cell
recruitment. Cancer Cell 15, 527-538.
Chen, P., Huang, Y., Bong, R., Ding, Y., Song, N., Wang, X., Song, X., Luo, Y., 2011. Tumor-
associated macrophages promote angiogenesis and melanoma growth via adrenomedul-
lin in a paracrine and autocrine manner. Clin. Cancer Res. 17, 7230-7239.
Chen, W., Liu, J., Meng, J., Lu, C., Li, X., Wang, E., Shan, F., 2012a. Macrophage polariza-
tion induced by neuropeptide methionine enkephalin (MENK) promotes tumoricidal
responses. Cancer Immunol. Immunother. 61, 1755-1768.
Chen, W., Ma, T., Shen, X.N., Xia, X.F., Xu, G.D., Bai, X.L., Liang, T.B., 2012b. Macrophage-
induced tumor angiogenesis is regulated by the TSC2-mTOR pathway. Cancer Res. 72,
1363-1372.
Search WWH ::
Custom Search